Additional baricitinib loading dose improves clinical outcome in COVID-19

Pneumonia associated with coronavirus disease 2019 (COVID-19) has been accounted for high mortality rate in severe COVID-19 worldwide, and additional serious scarcity of standard and effective anti-inflammatory drug in COVID-19 pneumonia management is a big challenge. Baricitinib, a Janus kinase (JA...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hasan Md Jahidul, Rabbani Raihan, Anam Ahmad Mursel, Huq Shihan Mahmud Redwanul
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2020
Materias:
R
Acceso en línea:https://doaj.org/article/fa98f059064f41fa9868c28725b9263a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!